This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Colombel, M. Articles by Buttyan, R. Search for Related Content PubMed PubMed Citation Articles by Colombel, M. Articles by Buttyan, R.

Hormone-regulated Apoptosis Results from Reentry of Differentiated Prostate Cells onto a Defective Cell Cycle¹

Department of Urology, Columbia University, College of Physicians and Surgeons, New York, New York 10032

Castration initiates extensive apoptosis of the secretory epithelial cells lining the ducts of the rat ventral prostate, resulting in the striking regression of this male sexual accessory tissue. We had previously described the paradox of finding similar cascades of gene activity (c-fos > c-myc > hsp-70) induced during the early period of ventral prostate regression and during the regrowth of the ventral prostate gland initiated by testosterone replenishment. This common pattern of protooncogene expression during periods of predominant cellular apoptosis or proliferation caused us to examine further the possibility that the two cellular events occur through identical early molecular pathways. In the present study we demonstrate that apoptotic prostate epithelial cells incorporate bromodeoxyuridine into nuclear high-molecular-weight DNA prior to nuclear DNA fragmentation. The DNA synthetic activity occurs in coordination with a massive induction of proliferative cell nuclear antigen, a proliferation marker, in the nuclei of androgen-deprived prostatic epithelial cells. Moreover, this activity is also associated with the increased expression of mRNA encoding p53, a suppressor gene well known as a cell cycle-blocking agent. Our data indicate that quiescent (G₀) prostate epithelial cells undergo apoptosis due to two sequential events initiated by testosterone depletion. The first event is the active reentry of these cells into the cell cycle. The second event is the apoptotic destruction resulting from the inability of the differentiated cells to successfully complete this cycle.

¹ Supported by a grant from the National Cancer Institute (NIH CA47848).

² To whom requests for reprints should be addressed, at Department of Urology, Columbia University, College of Physicians and Surgeons, 630 W. 168 Street, New York, NY 10032.

Received 3/ 9/92. Accepted 6/ 8/92.

This article has been cited by other articles:

				M. E. Grossmann, H. Huang, and D. J. Tindall Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer J Natl Cancer Inst, November 21, 2001; 93(22): 1687 - 1697. [Abstract] [Full Text] [PDF]

				H. Huang, J. C. Cheville, Y. Pan, P. C. Roche, L. J. Schmidt, and D. J. Tindall PTEN Induces Chemosensitivity in PTEN-mutated Prostate Cancer Cells by Suppression of Bcl-2 Expression J. Biol. Chem., October 12, 2001; 276(42): 38830 - 38836. [Abstract] [Full Text] [PDF]

				A. Lacoste, M.-C. De Cian, A. Cueff, and S. A. Poulet Noradrenaline and {alpha}-adrenergic signaling induce the hsp70 gene promoter in mollusc immune cells J. Cell Sci., January 10, 2001; 114(19): 3557 - 3564. [Abstract] [Full Text] [PDF]

				H. Perlman, C. Georganas, L. J. Pagliari, A. E. Koch, K. Haines III, and R. M. Pope Bcl-2 Expression in Synovial Fibroblasts Is Essential for Maintaining Mitochondrial Homeostasis and Cell Viability J. Immunol., May 15, 2000; 164(10): 5227 - 5235. [Abstract] [Full Text] [PDF]

				J. Jongsma, M. H. Oomen, M. A. Noordzij, W. M. Van Weerden, G. J. M. Martens, T. H. van der Kwast, F. H. Schröder, and G. J. van Steenbrugge Androgen Deprivation of the Prohormone Convertase-310 Human Prostate Cancer Model System Induces Neuroendocrine Differentiation Cancer Res., February 1, 2000; 60(3): 741 - 748. [Abstract] [Full Text]

				M. Sakurai, T. Hayashi, K. Abe, Y. Itoyama, K. Tabayashi, and W. I. Rosenblum Cyclin D1 and Cdk4 Protein Induction in Motor Neurons After Transient Spinal Cord Ischemia in Rabbits Editorial Comment Stroke, January 1, 2000; 31(1): 200 - 207. [Abstract] [Full Text] [PDF]

				E. Gould, A. J. Reeves, M. S. Graziano, and C. G. Gross Neurogenesis in the Neocortex of Adult Primates Science, October 15, 1999; 286(5439): 548 - 552. [Abstract] [Full Text]

				L. Cheng, T. M. Pisansky, T. J. Sebo, B. C. Leibovich, D. M. Ramnani, A. L. Weaver, B. G. Scherer, M. L. Blute, H. Zincke, and D. G. Bostwick Cell Proliferation in Prostate Cancer Patients with Lymph Node Metastasis: A Marker for Progression Clin. Cancer Res., October 1, 1999; 5(10): 2820 - 2823. [Abstract] [Full Text] [PDF]

				J. W. Choi and S. E. Jung Lovastatin-Induced Proliferation Inhibition and Apoptosis in C6 Glial Cells J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 572 - 579. [Abstract] [Full Text]

				J. Jongsma, M. H. Oomen, M. A. Noordzij, W. M. Van Weerden, G. J. M. Martens, T. H. van der Kwast, F. H. Schroder, and G. J. van Steenbrugge Kinetics of Neuroendocrine Differentiation in an Androgen-Dependent Human Prostate Xenograft Model Am. J. Pathol., February 1, 1999; 154(2): 543 - 551. [Abstract] [Full Text] [PDF]

				N. Malik, S. E. Francis, C. M. Holt, J. Gunn, G. L. Thomas, L. Shepherd, J. Chamberlain, C. M. H. Newman, D. C. Cumberland, and D. C. Crossman Apoptosis and Cell Proliferation After Porcine Coronary Angioplasty Circulation, October 20, 1998; 98(16): 1657 - 1665. [Abstract] [Full Text] [PDF]

				Y. Soini, P. Paakko, and V-P. Lehto Histopathological Evaluation of Apoptosis in Cancer Am. J. Pathol., October 1, 1998; 153(4): 1041 - 1053. [Full Text] [PDF]

				P. Waring, T. Khan, and A. Sjaarda Apoptosis Induced by Gliotoxin Is Preceded by Phosphorylation of Histone H3 and Enhanced Sensitivity of Chromatin to Nuclease Digestion J. Biol. Chem., July 18, 1997; 272(29): 17929 - 17936. [Abstract] [Full Text] [PDF]

				H. Perlman, L. Maillard, K. Krasinski, and K. Walsh Evidence for the Rapid Onset of Apoptosis in Medial Smooth Muscle Cells After Balloon Injury Circulation, February 18, 1997; 95(4): 981 - 987. [Abstract] [Full Text]

				Y. Furukawa, S. Iwase, Y. Terui, J. Kikuchi, T. Sakai, M. Nakamura, S. Kitagawa, and M. Kitagawa Transcriptional Activation of the cdc2 Gene Is Associated with Fas-induced Apoptosis of Human Hematopoietic Cells J. Biol. Chem., November 8, 1996; 271(45): 28469 - 28477. [Abstract] [Full Text] [PDF]

				C. Borner and C. Borner Diminished Cell Proliferation Associated with the Death-protective Activity of Bcl-2 J. Biol. Chem., May 31, 1996; 271(22): 12695 - 12698. [Abstract] [Full Text] [PDF]

				D. S. Park, S. E. Farinelli, and L. A. Greene Inhibitors of Cyclin-dependent Kinases Promote Survival of Post-mitotic Neuronally Differentiated PC12 Cells and Sympathetic Neurons J. Biol. Chem., April 5, 1996; 271(14): 8161 - 8169. [Abstract] [Full Text] [PDF]

				M. R. Bennett, G. I. Evan, and S. M. Schwartz Apoptosis of Rat Vascular Smooth Muscle Cells Is Regulated by p53-Dependent and -Independent Pathways Circ. Res., August 1, 1995; 77(2): 266 - 273. [Abstract] [Full Text]

				M.-E. Taplin, G. J. Bubley, T. D. Shuster, M. E. Frantz, A. E. Spooner, G. K. Ogata, H. N. Keer, and S. P. Balk Mutation of the Androgen-Receptor Gene in Metastatic Androgen-Independent Prostate Cancer N. Engl. J. Med., May 25, 1995; 332(21): 1393 - 1398. [Abstract] [Full Text] [PDF]

				C. Thompson Apoptosis in the pathogenesis and treatment of disease Science, March 10, 1995; 267(5203): 1456 - 1462. [Abstract] [PDF]